Managed Care Stocks Surge to Three-Month High Following Medicare Advantage Rate Increase
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1 hour ago
0mins
Should l Buy UNH?
Source: seekingalpha
- Medicare Rate Boost: The Centers for Medicare & Medicaid Services (CMS) finalized a 2.48% reimbursement rate increase for Medicare Advantage plans for 2027, significantly higher than the earlier proposed 0.09%, injecting over $13 billion into the system, which is expected to enhance profitability and investment appeal for insurers.
- Positive Market Reaction: The S&P 1500 Managed Care Index surged approximately 8%, reaching its highest level since late January, reflecting optimistic market sentiment regarding the future profitability of health insurers, particularly leading players like UnitedHealth (UNH) and Humana (HUM).
- Analyst Outlook: Oppenheimer analyst Michael Wiederhorn noted that despite regulatory pressures and rising medical utilization challenges, the favorable CMS adjustment may signal an improving industry environment, enhancing expectations for margin growth in 2026.
- Bullish Investment Recommendations: Analysts issued “Buy” ratings for UnitedHealth (UNH) and Elevance Health (ELV), viewing the Medicare Advantage rate increase as a “gift” that could shift market perceptions of their valuations, especially given their current deeply discounted metrics.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy UNH?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on UNH
Wall Street analysts forecast UNH stock price to rise
19 Analyst Rating
16 Buy
3 Hold
0 Sell
Strong Buy
Current: 281.360
Low
330.00
Averages
397.82
High
444.00
Current: 281.360
Low
330.00
Averages
397.82
High
444.00
About UNH
UnitedHealth Group Incorporated is a healthcare and well-being company. Its segments include Optum Health, Optum Insight, Optum Rx, and UnitedHealthcare, which includes UnitedHealthcare Employer & Individual, UnitedHealthcare Medicare & Retirement and UnitedHealthcare Community & State. Optum Health provides comprehensive and patient-centered care, addressing the physical, mental, and social well-being. Optum Health delivers primary, specialty and surgical care and helps patients and providers navigate and address complex, chronic and behavioral health needs. Optum Insight connects the healthcare system with services, analytics and platforms that make clinical, administrative and financial processes simpler and more efficient for all participants in the healthcare system. Optum Rx offers a range of pharmacy care services through retail pharmacies, through home delivery, specialty and community health pharmacies and the provision of in-home and community-based infusion services.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
UnitedHealth Shares Surge 8% on Medicare Payment Update
- Medicare Payment Increase: The Centers for Medicare & Medicaid Services confirmed a 2.48% increase in Medicare Advantage payments for 2027, improving from the nearly flat rate proposed in January, alleviating concerns about profit margins.
- Positive Stock Reaction: UnitedHealth's shares surged nearly 8% in after-hours trading on Monday, indicating investor optimism regarding the new payment policy, which could enhance the company's profitability and market confidence.
- Shareholder Structure Analysis: According to TipRanks data, public companies and individual investors hold about 49% of UnitedHealth, while mutual funds and ETFs account for nearly 27% and 22%, respectively, indicating a broad investor base.
- Major Shareholder Insights: Vanguard holds the largest stake at approximately 9%, with the Vanguard Total Stock Market ETF (VTI) owning over 3% and the Vanguard S&P 500 ETF (VOO) holding about 2.6%, reflecting institutional investors' significant interest in the company.
See More
UNITEDHEALTH: BOFA GLOBAL RESEARCH INCREASES PRICE TARGET TO $337, UP FROM $315
Global Health Research Funding: The United Health Foundation has raised its funding objective for global health research to $337 million, an increase from the previous target of $315 million.
Focus on Health Initiatives: The additional funds are aimed at enhancing health initiatives and addressing critical health challenges worldwide.
Impact on Communities: The funding is expected to support various programs that improve health outcomes in underserved communities globally.
Commitment to Health Equity: This increase reflects a commitment to promoting health equity and advancing research that can lead to better health solutions for diverse populations.
See More
Managed Care Stocks Surge to Three-Month High Following Medicare Advantage Rate Increase
- Medicare Rate Boost: The Centers for Medicare & Medicaid Services (CMS) finalized a 2.48% reimbursement rate increase for Medicare Advantage plans for 2027, significantly higher than the earlier proposed 0.09%, injecting over $13 billion into the system, which is expected to enhance profitability and investment appeal for insurers.
- Positive Market Reaction: The S&P 1500 Managed Care Index surged approximately 8%, reaching its highest level since late January, reflecting optimistic market sentiment regarding the future profitability of health insurers, particularly leading players like UnitedHealth (UNH) and Humana (HUM).
- Analyst Outlook: Oppenheimer analyst Michael Wiederhorn noted that despite regulatory pressures and rising medical utilization challenges, the favorable CMS adjustment may signal an improving industry environment, enhancing expectations for margin growth in 2026.
- Bullish Investment Recommendations: Analysts issued “Buy” ratings for UnitedHealth (UNH) and Elevance Health (ELV), viewing the Medicare Advantage rate increase as a “gift” that could shift market perceptions of their valuations, especially given their current deeply discounted metrics.
See More
US Stocks Decline as Oil Prices Surge Amid Iran Tensions
- Market Decline: The S&P 500 Index fell by 0.90%, the Dow Jones Industrial Average dropped by 0.76%, and the Nasdaq 100 Index decreased by 1.40%, reflecting investor concerns over geopolitical tensions, particularly the potential escalation of conflict between Iran and the US.
- Oil Price Surge: Crude oil prices rose over 3% to a four-week high as the market watches for Iran's response to a ceasefire deadline tonight, with failure to reach an agreement potentially leading to broader military conflict and impacting global energy supplies.
- Positive Economic Data: Despite the overall market downturn, February's non-defense capital goods new orders increased by 0.6% month-over-month, surpassing expectations of 0.5%, indicating resilience in US capital spending that could support future market stability.
- Bond Market Reaction: The 10-year Treasury note yield rose to 4.357% as rising oil prices boosted inflation expectations, while the market's diminished outlook for a Fed rate hike reflects investor caution regarding future economic policies.
See More
Apple Shares Drop Nearly 4% Amid Engineering Setbacks for Foldable iPhone
- Apple Stock Decline: Apple's shares fell nearly 4% on Tuesday, leading the S&P 500 lower, after Nikkei Asia reported setbacks in the engineering test phase for its planned foldable iPhone, which could adversely affect mass production and product shipments.
- Universal Music Group Surge: Shares of Universal Music Group surged almost 13% after hedge fund investor Bill Ackman's Pershing Square Capital Management offered to acquire the company in a cash and stock deal valued at approximately €55.8 billion ($64.4 billion), significantly boosting market expectations for its future.
- Arm Holdings Downgrade: Arm Holdings' stock dropped over 4% following Morgan Stanley's downgrade from overweight to equal weight, citing that the company's strategic pivot to chips amid the AI boom will take time, and near-term risks like rising R&D costs and DRAM shortages could weigh on the stock.
- Healthcare Stocks Bounce Back: Healthcare stocks rallied as the Center for Medicare & Medicaid Services finalized a payment increase for privately run Medicare Advantage plans, exceeding its initial proposal from January, with UnitedHealth jumping 10% and Humana and CVS Health rising 8% and 7%, respectively.
See More
Investors Lose Hope for Iran Deal, Stocks Decline
- Market Sentiment Declines: Stocks fell on Tuesday as investors lost hope for a U.S.-Iran agreement to reopen the Strait of Hormuz, reflecting market sensitivity to geopolitical risks after four consecutive positive sessions for the S&P 500.
- Apple Stock Pullback: Apple shares dropped over 3% following reports of delays in the shipment of the foldable iPhone, leading to a more than 10% decline from its February 6 closing high of $278.12, with Jim Cramer suggesting this dip presents a buying opportunity for new investors.
- Starbucks Strategic Shift: After a nearly 5% rise on Monday, Starbucks shares took a breather on Tuesday following its joint venture with Boyu Capital to sell 60% of its China business, aimed at accelerating long-term growth, with Jim indicating a potential reduction in position if the stock trends higher.
- Rapid Market Recap: Stocks mentioned in Tuesday's rapid-fire segment included UnitedHealth Group, CVS, and Humana, highlighting a focus on a diversified investment portfolio, with Jim Cramer's charitable trust holding positions in AAPL, SBUX, GS, and GOOGL.
See More
UnitedHealth Shares Surge 8% on Medicare Payment Update
- Medicare Payment Increase: The Centers for Medicare & Medicaid Services confirmed a 2.48% increase in Medicare Advantage payments for 2027, improving from the nearly flat rate proposed in January, alleviating concerns about profit margins.
- Positive Stock Reaction: UnitedHealth's shares surged nearly 8% in after-hours trading on Monday, indicating investor optimism regarding the new payment policy, which could enhance the company's profitability and market confidence.
- Shareholder Structure Analysis: According to TipRanks data, public companies and individual investors hold about 49% of UnitedHealth, while mutual funds and ETFs account for nearly 27% and 22%, respectively, indicating a broad investor base.
- Major Shareholder Insights: Vanguard holds the largest stake at approximately 9%, with the Vanguard Total Stock Market ETF (VTI) owning over 3% and the Vanguard S&P 500 ETF (VOO) holding about 2.6%, reflecting institutional investors' significant interest in the company.
See More
UNITEDHEALTH: BOFA GLOBAL RESEARCH INCREASES PRICE TARGET TO $337, UP FROM $315
Global Health Research Funding: The United Health Foundation has raised its funding objective for global health research to $337 million, an increase from the previous target of $315 million.
Focus on Health Initiatives: The additional funds are aimed at enhancing health initiatives and addressing critical health challenges worldwide.
Impact on Communities: The funding is expected to support various programs that improve health outcomes in underserved communities globally.
Commitment to Health Equity: This increase reflects a commitment to promoting health equity and advancing research that can lead to better health solutions for diverse populations.
See More
Managed Care Stocks Surge to Three-Month High Following Medicare Advantage Rate Increase
- Medicare Rate Boost: The Centers for Medicare & Medicaid Services (CMS) finalized a 2.48% reimbursement rate increase for Medicare Advantage plans for 2027, significantly higher than the earlier proposed 0.09%, injecting over $13 billion into the system, which is expected to enhance profitability and investment appeal for insurers.
- Positive Market Reaction: The S&P 1500 Managed Care Index surged approximately 8%, reaching its highest level since late January, reflecting optimistic market sentiment regarding the future profitability of health insurers, particularly leading players like UnitedHealth (UNH) and Humana (HUM).
- Analyst Outlook: Oppenheimer analyst Michael Wiederhorn noted that despite regulatory pressures and rising medical utilization challenges, the favorable CMS adjustment may signal an improving industry environment, enhancing expectations for margin growth in 2026.
- Bullish Investment Recommendations: Analysts issued “Buy” ratings for UnitedHealth (UNH) and Elevance Health (ELV), viewing the Medicare Advantage rate increase as a “gift” that could shift market perceptions of their valuations, especially given their current deeply discounted metrics.
See More
US Stocks Decline as Oil Prices Surge Amid Iran Tensions
- Market Decline: The S&P 500 Index fell by 0.90%, the Dow Jones Industrial Average dropped by 0.76%, and the Nasdaq 100 Index decreased by 1.40%, reflecting investor concerns over geopolitical tensions, particularly the potential escalation of conflict between Iran and the US.
- Oil Price Surge: Crude oil prices rose over 3% to a four-week high as the market watches for Iran's response to a ceasefire deadline tonight, with failure to reach an agreement potentially leading to broader military conflict and impacting global energy supplies.
- Positive Economic Data: Despite the overall market downturn, February's non-defense capital goods new orders increased by 0.6% month-over-month, surpassing expectations of 0.5%, indicating resilience in US capital spending that could support future market stability.
- Bond Market Reaction: The 10-year Treasury note yield rose to 4.357% as rising oil prices boosted inflation expectations, while the market's diminished outlook for a Fed rate hike reflects investor caution regarding future economic policies.
See More
Apple Shares Drop Nearly 4% Amid Engineering Setbacks for Foldable iPhone
- Apple Stock Decline: Apple's shares fell nearly 4% on Tuesday, leading the S&P 500 lower, after Nikkei Asia reported setbacks in the engineering test phase for its planned foldable iPhone, which could adversely affect mass production and product shipments.
- Universal Music Group Surge: Shares of Universal Music Group surged almost 13% after hedge fund investor Bill Ackman's Pershing Square Capital Management offered to acquire the company in a cash and stock deal valued at approximately €55.8 billion ($64.4 billion), significantly boosting market expectations for its future.
- Arm Holdings Downgrade: Arm Holdings' stock dropped over 4% following Morgan Stanley's downgrade from overweight to equal weight, citing that the company's strategic pivot to chips amid the AI boom will take time, and near-term risks like rising R&D costs and DRAM shortages could weigh on the stock.
- Healthcare Stocks Bounce Back: Healthcare stocks rallied as the Center for Medicare & Medicaid Services finalized a payment increase for privately run Medicare Advantage plans, exceeding its initial proposal from January, with UnitedHealth jumping 10% and Humana and CVS Health rising 8% and 7%, respectively.
See More
Investors Lose Hope for Iran Deal, Stocks Decline
- Market Sentiment Declines: Stocks fell on Tuesday as investors lost hope for a U.S.-Iran agreement to reopen the Strait of Hormuz, reflecting market sensitivity to geopolitical risks after four consecutive positive sessions for the S&P 500.
- Apple Stock Pullback: Apple shares dropped over 3% following reports of delays in the shipment of the foldable iPhone, leading to a more than 10% decline from its February 6 closing high of $278.12, with Jim Cramer suggesting this dip presents a buying opportunity for new investors.
- Starbucks Strategic Shift: After a nearly 5% rise on Monday, Starbucks shares took a breather on Tuesday following its joint venture with Boyu Capital to sell 60% of its China business, aimed at accelerating long-term growth, with Jim indicating a potential reduction in position if the stock trends higher.
- Rapid Market Recap: Stocks mentioned in Tuesday's rapid-fire segment included UnitedHealth Group, CVS, and Humana, highlighting a focus on a diversified investment portfolio, with Jim Cramer's charitable trust holding positions in AAPL, SBUX, GS, and GOOGL.
See More
